Free Republic

-The FDA warned Wednesday that relying on antibodies for protection from COVID-19 may leave people vulnerable -A vaccine is still needed to confirm immunity from the effects of the virus -Positive antibody tests also won't work as a substitute for proof of vaccination because the blood screening looks for different proteins than shots trigger -Brief comes as vaccine progress in the United States slows down Testing positive for COVID-19 antibodies is not sufficient replacement for receiving the vaccine, according to a briefing released by the Food and Drug Administration (FDA) on Wednesday.

Asthma affects hundreds of millions of people around the world, but an experimental vaccine offers new hope to successfully treat this chronic lung disease, linked to hundreds of thousands of deaths each year. So far the prototype vaccine has only been tested in animals, but the researchers now intend to conduct a clinical trial in human patients – with hopes the approach could provide a safe, cost-effective, and long-term way to protect people from allergic asthma attacks. "The idea is to set up in the future a preventive approach for populations at risk of developing a severe form of asthma,"...

When President Trump emerged from Walter Reed Medical Center, he seemed pretty convinced that the treatment he was given was a cure for COVID-19. He reported feeling better almost immediately after being given Regeneron, a polyclonal antibody formula. Yesterday, Regeneron published the results of the first three phases of their trials for treating COVID-19. Regeneron has completed the required randomized, double-blind studies that Dr. Fauci insisted on. At the end of September, the company reported that the treatment reduced viral levels in a study of 275 patients who had no evidence of an immune response before receiving the therapy: “After...

Scientists at the University of Pittsburgh School of Medicine have isolated the biomolecule Scientists at the University of Pittsburgh School of Medicine have isolated “the smallest biological molecule” that “completely and specifically neutralizes” SARS-CoV-2, the virus that causes the novel coronavirus. The antibody component is 10 times smaller than a full-sized antibody, and has been used to create the drug Ab8, shared in the report published by the researchers in the journal Cell on Monday. The drug is seen as a potential preventative against SARS-CoV-2. According to the report, the drug has been “highly effective in preventing and treating” the...

I was going to write about the new Reese’s peanut butter cup with potato chips in the filling but I suppose this is the more newsworthy breakthrough of the two.This isn’t as good as a vaccine but if it pans out it’d be the next best thing. It’s an antibody treatment — or, more specifically, a treatment involving an antibody component. Scientists at the University of Pittsburgh realized that you don’t need whole entire intact antibodies to fight off COVID; what you need is something that’ll bind to the virus’s “spike” protein, thereby blocking it from attaching itself to...

A team of scientists at the Anschutz Medical Campus is racing to create a new, high-quality antibody test that could be scaled to provide plenty of tests to people throughout Colorado in the coming months.

It’s just the flu, bro. One of the best ways to keep the pandemic going is to use tests with a high false positive rate coupled with mandatory testing. Force 1000 people to take a test and if you get 50 false positives then you have a perpetual lockdown. Apparently some tests have low false positives (nasal swab) and some have higher false positives (antibody). - If you are wondering how much people who live and were raised in a western democracy would be willing to give up their freedoms due to COVID then I think the state of Victoria...

In 2015 the Deep State, lead by Hillary Clinton, attempted to take out the ONLY antibody treatment that prevents and ends the Cytokine Storm (which now appears to end Covid 19 in 100% of patients). The antibody treatment is being tested by the FDA right now. Trump needs to have people watching the test results so that the FDA does not pull off what it did with Hydroxychloroquine. * We cannot let Gilead buy this company as it looks like they may. They want to have it under their control and pair it with Remdesivir * We cannot let the...

TOPLINE In updated guidance posted on its website over the weekend, the U.S. Centers for Disease Control and Prevention acknowledged an inability to accurately determine if individuals had been infected with Covid-19 via antibody tests; if the test is used in a population where prevalence is low, it's possible that "less than half of those testing positive will truly have antibodies."

The Israeli chief medical officer of US biotech firm Moderna said Monday that its experimental anti-COVID-19 vaccine “actually works,” after tests on a small number volunteers, and that it will start Phase 3 testing on thousands of people in July. “We got the first results today… and today we are showing that it actually works… we are able to stimulate the immune system,” Dr. Tal Zaks said. In an interview with Israeli television, Zaks said he was confident that, toward the end of the year, “we’ll be able to present first results that prove that our vaccine indeed prevents the...

Tiny biotech company Sorrento Therapeutics (SRNE) claimed Friday its experimental coronavirus treatment is a cure for Covid-19. Meanwhile, another company said it gained authorization for a coronavirus test. In preclinical testing, Sorrento's antibody drug provided "100% inhibition" of SARS-CoV-2 — the new coronavirus that causes Covid-19 — within four days. Sorrento expects this antibody to be the first in a drug cocktail that would create a "protective shield" against infection. "Our STI-1499 antibody shows exceptional therapeutic potential and could potentially save lives following receipt of necessary approvals," Chief Executive Henry Ji said in a written statement. "We at Sorrento are...

It could take more than a year before a vaccine for the new coronavirus is available, and even that may be a wildly optimistic timeline, since the average vaccine development process takes 10.7 years. (On the other end of the spectrum, University of Oxford researchers say that they could have a million doses of their experimental vaccine ready by this September, and Chinese researchers have predicted the same for another vaccine.) But before a vaccine is ready, it’s possible that antibody treatments could become more widely used. Traditional vaccines work by weakening a virus so that it can’t get you...

AN antibody which prevents coronavirus from infecting human cells has been discovered by scientists. Researchers from Utrecht University in the Netherlands, as well as the Erasmus Medical Centre and the company Harbour BioMed (HBM), identified it as a potential method of neutralising Covid-19. And while the team's discovery was made on human cells grown in the laboratory - they are hopeful it will have the same effect on patients. The breakthrough offers hope of a treatment or even a vaccine for the deadly virus, which has infected more than 3.5 million people worldwide, and led to more than 248,000 deaths....

My Quest Diagnostics anti-body test was negative. I can't help but feel that there is something fishy with this and the other tests that are being pushed on us. It seems almost impossible to me that I was not exposed to the novel coronavirus. Here is why I feel that way: 1. About a week after sitting for 3 hours in an enclosed room to hear a young pastor's oral ordination exam, a fellow examiner alerted me that he had tested positive for the virus and his whole house was on lockdown (end of March). Three members of this pastor's...

Touted as society’s way out of widespread lockdowns, scientists say the true potential of these rapidly developed tests is still unknown.

Over 3,200 people in Santa Clara County were tested for COVID-19 antibodies on Friday and Saturday in an effort to determine the proportion of the population that either has or has recovered from coronavirus. The study, led by researchers at Stanford Medicine, is the first of its kind in the nation. The results, expected to be released within a week, could be used to guide future public health policy in the county, according to associate professor of medicine and study co-lead Eran Bendavid.

Six sites across Los Angeles County will be used to test for coronavirus antibodies in 1,000 people to find out how many have already fought off the virus, USC Price School of Public Policy officials said Thursday. The pilot serology tests will start on Friday and Saturday and take place at drive-thru sites throughout the county every two weeks to track the trajectory of the pandemic, according to a news release from the school. Working with the L.A. County Department of Public Health, the school said it hopes to find if people have the antibodies or immune cells that potentially...

The Food and Drug Administration on Thursday authorized its first emergency use coronavirus serology test, opening the way for a possible treatment for COVID-19, which has infected some 1 million worldwide and killed more than 51,000. The test will determine if a person has been infected. The test was developed by Cellex Inc. and involves a blood draw done at a certified lab. It can provide results in 15 minutes. “Based on the totality of scientific evidence available to FDA, it is reasonable to believe that your product may be effective in diagnosing COVID-19,” FDA chief scientist Denise M. Hinton...

As I understand it, there are three potential pharmaceutical defenses to COVID-19 (or any other virus). * One is a vaccine, the holy grail, which durably prevents infection.* The second is antiviral medication, to treat those who’ve already been infected.* The third is antibody therapy, which can be used either to prevent infection or to treat those who are sick. The bad news with antibody therapy is that it’s not durable like a vaccine; the antibodies degrade after a period of weeks or months. The good news is that it’s the easiest of the three defenses to develop. Because...

While it might be impossible to figure out who is going to become sick with novel coronavirus, some public health experts believe the more critical question may be who has already been exposed. In Telluride, Colorado, last week, one biotech company put that idea to work. United Biomedical is now working with San Miguel County, which includes the famous Rocky Mountain ski destination, to test all 8,000 residents for COVID-19 antibodies -- making it the first community in the country to do widespread antibody testing. The idea, officials said, is to learn from an individual’s blood whether there is evidence...